Name: | Description: | Size: | Format: | |
---|---|---|---|---|
2.07 MB | Adobe PDF |
Advisor(s)
Abstract(s)
The endocannabinoid system (ECS) plays a very important role in numerous physiological
and pharmacological processes, such as those related to the central nervous system (CNS), including
learning, memory, emotional processing, as well pain control, inflammatory and immune response,
and as a biomarker in certain psychiatric disorders. Unfortunately, the half-life of the natural
ligands responsible for these effects is very short. This perspective describes the potential role of the
inhibitors of the enzymes fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MGL),
which are mainly responsible for the degradation of endogenous ligands in psychic disorders and
related pathologies. The examination was carried out considering both the impact that the classical
exogenous ligands such as ∆
9
-tetrahydrocannabinol (THC) and (−)-trans-cannabidiol (CBD) have on
the ECS and through an analysis focused on the possibility of predicting the potential toxicity of the
inhibitors before they are subjected to clinical studies. In particular, cardiotoxicity (hERG liability),
probably the worst early adverse reaction studied during clinical studies focused on acute toxicity,
was predicted, and some of the most used and robust metrics available were considered to select
which of the analyzed compounds could be repositioned as possible oral antipsychotics.
Description
Keywords
Endocannabinoid system FAAH inhibitors MGL inhibitors Repositioning Drug-likeness hERG Ligand efficiency metrics . Faculdade de Ciências Exatas e da Engenharia Centro de Química da Madeira
Citation
Mangiatordi, G.F.; Cavalluzzi, M.M.; Delre, P.; Lamanna, G.; Lomuscio, M.C.; Saviano, M.; Majoral, J.-P.; Mignani, S.; Duranti, A.; Lentini, G. Endocannabinoid Degradation Enzyme Inhibitors as Potential Antipsychotics: A Medicinal Chemistry Perspective. Biomedicines 2023, 11, 469. https://doi.org/ 10.3390/biomedicines11020469
Publisher
MDPI